Long-Term Cardiovascular, Thromboembolic, and Malignancy Safety of Janus Kinase (JAK) Inhibitors in Dermatologic and Rheumatologic Populations: A Narrative Comparative Review.
Bou Rolon S, Ortiz Echevarria AN, Burgos Claudio M, Solis Esquilin EA, Rodriguez Ramirez PJ
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.